Immix Biopharma, Inc. announced a strong safety profile for its CAR-T therapy, NXC-201, including no reports of neurotoxicity in patients with low-volume disease.

Immix Biopharma does not undertake, and specifically disclaims, any obligation to update or revise such statements to reflect new circumstances or unanticipated events as they occur, except as ...

As of Friday, June 27, Connect Biopharma Holdings Limited’s CNTB share price has surged by 7.16%, which has investors questioning if this is right time to sell.

SAN DIEGO, July 09, 2025 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (“Connect Biopharma”, “Connect”, or the “Company”), a clinical-stage biopharmaceutical company focused on ...

Press Releases Aspire Biopharma Holdings, Inc., Announces Positive Consumer Feedback from Company Sampling of BUZZ BOMB (TM), its New Sublingual Pre-Workout Supplement ...

Aspire Biopharma Holdings, Inc., Announces Positive Consumer Feedback from Company Sampling of BUZZ BOMB (TM), its New Sublingual Pre-Workout Supplement Written by aspire biopharma holdings inc.

BEIJING, July 8, 2025 /PRNewswire/ -- LakeShore Biopharma Co., Ltd (Nasdaq: LSB) (the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering ...

Centene, BrightView Holdings, ArriVent BioPharma And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session by Avi Kapoor Benzinga Staff Writer Follow Add Comment | ...